Walleye Capital
PBMWW

Walleye Capital’s Psyence Biomedical Warrant PBMWW Stock Holding History

Walleye Capital’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,282
Closed -$494 – 5271
2024
Q4 		$494 Sell
34,282
-164,014
-83% -$2.18K ﹤0.01% 4723
2024
Q3 		$2.5K Hold
198,296
– – ﹤0.01% 5069
2024
Q2 		$2.08K Hold
198,296
– – ﹤0.01% 5419
2024
Q1 		$13.9K Buy
+198,296
New +$12.4K ﹤0.01% 5003

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Walleye Capital's PBMWW Position: Q1 2025 in Review

Walleye Capital sold out of Psyence Biomedical Warrant (PBMWW) in Q1 2025, closing a stake of 34,282 shares — an estimated $494 sold.

Walleye Capital first reported a position in PBMWW in Q1 2024 and held it in 4 quarters. The position peaked at $13.9K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q1 2025.

  • Walleye Capital reported no remaining Psyence Biomedical Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 34,282 Psyence Biomedical Warrant shares in Q1 2025, an estimated $494.
  • Walleye Capital first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 4 quarters.
  • Walleye Capital's Psyence Biomedical Warrant position peaked at $13.9K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.